Medical terminology

iXensor Levels Up PixoTest Covid-19 Ag Test With The Launch Of PixoHealth Data Management Platform As The Security Solution For The New Normalcy

Tuesday, July 27, 2021 - 12:32pm

In addition, the PixoHealth Pass Admin Web Portal synchronizes multi-source COVID-19 related health data and rapid test results from PixoHealth Pass App users and PixoTest POCT Analyzer simultaneously.

Key Points: 
  • In addition, the PixoHealth Pass Admin Web Portal synchronizes multi-source COVID-19 related health data and rapid test results from PixoHealth Pass App users and PixoTest POCT Analyzer simultaneously.
  • The utilization of PixoHealth Pass Admin Web Portal, PixoTest POCT Analyzer and PixoHealth Pass App fully digitizes the data management processes with a one-time setup.
  • In addition, PixoHealth Pass Admin App allows organizations to configure health-data based access management rules for keeping SARS-CoV-2 from causing cluster infections.
  • In 2017, iXensor introduced the PixoTest Blood Glucose Monitoring System as the world's first US FDA-approved smartphone camera-based blood test.

iXensor Levels Up PixoTest® COVID-19 Ag Test With the Launch of PixoHealth Data Management Platform as the Security Solution for the New Normalcy

Tuesday, July 27, 2021 - 7:30am
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210726005852/en/
    PixoHealth Pass Admin Solution empowers sustainable, safe reopening together with PixoTest POCT COVID-19 Antigen Test.
  • (Photo: Business Wire)
    iXensor launches the next generation of integrated COVID-19 screening solution, the PixoHealth Pass Admin App and Web Portal .
  • In addition, the PixoHealth Pass Admin Web Portal synchronizes multi-source COVID-19 related health data and rapid test results from PixoHealth Pass App users and PixoTest POCT Analyzer simultaneously.
  • The utilization of PixoHealth Pass Admin Web Portal, PixoTest POCT Analyzer and PixoHealth Pass App fully digitizes the data management processes with a one-time setup.

Independent Consumer Research Reveals 25% of Insured Adults Delayed Emergency or Essential Treatment During Pandemic

Monday, July 26, 2021 - 6:07pm

Fifty-five percent of consumers who delayed care reported they had skipped routine preventive care.

Key Points: 
  • Fifty-five percent of consumers who delayed care reported they had skipped routine preventive care.
  • Nearly three-quarters of insured Americans (72 percent) credit their health plans with keeping them informed about COVID-19 testing, vaccines and other pandemic information during the previous year.
  • HealthEdge commissioned the independent survey of 3,000 American adults (26 years and older), who have health insurance.
  • Pollfish is an agile market research platform offering real-time responses from mobile consumers using a modern sampling methodology called Organic Sampling .

Acute On Chronic Liver Failure (ACLF) Epidemiology Forecast Research Report 2021-2030 - ResearchAndMarkets.com

Monday, July 26, 2021 - 10:55am

The "Acute On Chronic Liver Failure (ACLF) - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Acute On Chronic Liver Failure (ACLF) - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'Acute-On-Chronic Liver Failure ACLF)-Epidemiology Forecast - 2030' report delivers an in-depth understanding of the Acute-On-Chronic Liver Failure (ACLF), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Acute-On-Chronic Liver Failure (ACLF) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries.
  • The disease epidemiology covered in the report provides historical as well as forecasted Acute-On-Chronic Liver Failure (ACLF) epidemiology segmented as the Total Cases of Acute-On-Chronic Liver Failure (ACLF), Cases of Acute-On-Chronic Liver Failure (ACLF) by Grades, Organ Failure Associated with Acute-On-Chronic Liver Failure, Potential participating events of Acute-On-Chronic Liver Failure.

Adventist Health Taps GetWellNetwork as Innovation Partner To Reimagine the Consumer Experience in Digital Healthcare

Monday, July 26, 2021 - 3:00pm

Adventist Health has embarked on a bold plan to transform health and well-being for everyone it serves.

Key Points: 
  • Adventist Health has embarked on a bold plan to transform health and well-being for everyone it serves.
  • GetWellNetwork will help coordinate a smooth consumer experience across multiple channels including artificial intelligence-enabled texting, live customer navigation, comprehensive digital care plans, and a fully integrated and mobile inpatient experience.
  • Were deeply committed to the 2030 plan Im confident it will reshape the future of healthcare, said Jason Wells, chief strategy, consumer and innovation officer at Adventist Health.
  • Adventist Health and GetWellNetwork will also jointly develop GetWell Anywhere mobile application to improve digital coordination of the customer experience.

FORCE Family Office To Host Cancer Moonshot Symposium

Monday, July 26, 2021 - 11:26pm

NEW YORK, July 26, 2021 /PRNewswire/ -- In 2016, then Vice President Joe Biden announced the launch of the National Cancer Moonshot.

Key Points: 
  • NEW YORK, July 26, 2021 /PRNewswire/ -- In 2016, then Vice President Joe Biden announced the launch of the National Cancer Moonshot.
  • This initiative has the goal of making a decade's worth of progress in just five years in the prevention, diagnosis, and treatment of cancer, a disease that takes 1,800 lives per day.
  • Now that five years have elapsed, it's time to assess the progress that's been made.
  • They introduce members of their network to leaders of public companies and privately held businesses at the capital acquisition stage.

CityHealth Launches RapidReturn COVID-19 Travel Kit

Monday, July 26, 2021 - 9:40pm

The RapidReturn Kit allows US-bound travelers to take a supervised Rapid Antigen test and receive travel-approved results from anywhere in the world.

Key Points: 
  • The RapidReturn Kit allows US-bound travelers to take a supervised Rapid Antigen test and receive travel-approved results from anywhere in the world.
  • Priced at just $75 per kit, each kit contains 2 tests.
  • One kit per traveler is recommended, so travelers are prepared for flight delays or inconclusive results that require a second test.
  • CityHealth's RapidReturn Kit is one of the most affordable and user-friendly pre-travel COVID test kits on the market.

Insights Extracorporeal Membrane Oxygenation Machine Global Market to 2025 - Miniaturization of ECMO Machines Presents Opportunities - ResearchAndMarkets.com

Friday, July 23, 2021 - 2:35pm

The "Global Extracorporeal Membrane Oxygenation Machine Market (2020-2025) by Components, Modality, Application, Patient Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Extracorporeal Membrane Oxygenation Machine Market (2020-2025) by Components, Modality, Application, Patient Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be USD 295.3 Mn in 2020 and is expected to reach USD 467.2 Mn by 2025, growing at a CAGR of 9.6%.
  • The Global Extracorporeal Membrane Oxygenation Machine Market is segmented further based on Components, Modality, Application, Patient Type, End-User, and Geography.
  • The report offers a comprehensive evaluation of the Global Extracorporeal Membrane Oxygenation Machine Market.

Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums

Thursday, July 22, 2021 - 5:45pm

For many establishments, the tests help to assess levels of risk for patrons, employees and other interested parties.

Key Points: 
  • For many establishments, the tests help to assess levels of risk for patrons, employees and other interested parties.
  • Now the FDA has released guidance to BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) for its T-cell immune response diagnostic platform CoviDTH to begin Phase I/II Clinicial Trials.
  • However, later in July, Abbott was reported to be working to import the PanBio Covid-19 self tests from Korea.
  • The Sofia test was the first rapid antigen test to get an FDA greenlight , back in May of last year.

Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums

Thursday, July 22, 2021 - 5:45pm

VANCOUVER, B.C., July 22, 2021 /PRNewswire/ -- USA News Group  -  Two of the world's most prominent billionaires, George Soros and Bill Gates, recently made headlines backing a consortium to buy UK Covid-19 test maker Mologic for $41 million ahead of a new initiative of a global rollout for rapid result testing. As demand shifts, newer innovations from not only from Mologic are gaining attention, including a new T-Cell Immune Response diagnostic from BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV), antigen tests from Abbott Laboratories (NYSE: ABT), Chembio Diagnostics, Inc. (NASDAQ: CEMI) and Quidel Corporation (NASDAQ: QDEL), and antibody tests from Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX).

Key Points: 
  • For many establishments, the tests help to assess levels of risk for patrons, employees and other interested parties.
  • Now the FDA has released guidance to BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) for its T-cell immune response diagnostic platform CoviDTH to begin Phase I/II Clinicial Trials.
  • However, later in July, Abbott was reported to be working to import the PanBio Covid-19 self tests from Korea.
  • The Sofia test was the first rapid antigen test to get an FDA greenlight , back in May of last year.